Literature DB >> 30817292

Upfront cytoreductive nephrectomy vs. upfront systemic therapy in metastatic kidney cancer.

Anil Kapoor1, Emily C L Wong1, Wayne Fang1, Nathan C Wong1.   

Abstract

Entities:  

Year:  2019        PMID： 30817292     DOI： 10.5489/cuaj.5666

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  2 in total

Review 1.  Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.

Authors:  Walter R Hsiang; Patrick A Kenney; Michael S Leapman
Journal:  Curr Oncol Rep       Date:  2020-03-13       Impact factor: 5.075

2.  Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.

Authors:  Vinson Wai-Shun Chan; Wei Shen Tan; Jeffrey J Leow; Wei Phin Tan; William Lay Keat Ong; Peter Ka-Fung Chiu; Pratik Gurung; Giacomo Maria Pirola; Luca Orecchia; Matthew Ping Chao Liew; Hsiang-Ying Lee; Yuding Wang; I-Hsuan Alan Chen; Daniele Castellani; Marcelo Langer Wroclawski; Nikhil Mayor; Niranjan J Sathianathen; Isaac Braga; Zhenbang Liu; Dora Moon; Kari Tikkinen; Ashish Kamat; Max Meng; Vincenzo Ficarra; Gianluca Giannarini; Jeremy Yuen-Chun Teoh
Journal:  World J Urol       Date:  2021-05-24       Impact factor: 4.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.